ClinDatrix, Inc was contracted by Valeant Pharmaceuticals International, Inc. to provide full service clinincal research contracting for their phase 3 study of renu®. Valeant Pharmaceuticals is a wholly owned subsidiary, of Bausch + Lomb, a leading global eye health company.
Renu® is a New & Improved Formula Builds on Trusted 30-Year Heritage of Meeting Consumers’ Lens Care Solution Needs